# OnCo record denovo-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/denovo-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "denovo-biopharma" ;
  schema:name "Denovo Biopharma"@en ;
  schema:alternateName "Denovo Biopharma LLC"@en ;
  schema:description "Denovo is a San Diego biotech that revives failed drugs by finding the genetic marker of patients who did respond; it took enzastaurin back into phase 3 in lymphoma and glioblastoma with its DGM1 biomarker."@en ;
  schema:url <https://onco.cc/companies/denovo-biopharma/>, <https://denovobiopharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://denovobiopharma.com>, <https://clinicaltrials.gov/search?lead=Denovo%20Biopharma%20LLC>, <https://www.wikidata.org/wiki/Q140046004> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .
